Clinical trial
Parathyroid Hormone (PTH) With Alendronate for Osteoporosis
NCT00005006 · Helen Hayes Hospital, Other · Completed
Key facts
| NCT number | NCT00005006 |
|---|---|
| Title | Parathyroid Hormone (PTH) With Alendronate for Osteoporosis |
| Official title | Cyclical vs Daily Continuous PTH in Combination With Alendronate vs Alendronate Alone |
| Lead sponsor | Helen Hayes Hospital, Other |
| Collaborators | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Drug |
| Interventions | Parathyroid Hormone, Alendronate, Teriparatide |
| Enrollment | 140 |
| Start date | Sep 1, 1987 |
| Primary completion | Feb 1, 2003 |
| Completion | Dec 1, 2006 |
| First posted | Mar 27, 2000 |
| Last update posted | Aug 19, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: